News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Doyle Anthony
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/21/2022 |
4
| Doyle Anthony (CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 34,000 shares
@ $0
Granted 158,500 options to buy
@ $10.63, valued at
$1.7M
|
|
| 12/19/2022 |
4
| Doyle Anthony (CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Sold 5,700 shares
@ $10.9, valued at
$62.1k
|
|
| 01/13/2022 |
4/A
| Doyle Anthony (CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 75,000 shares
@ $0 |
|
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2021 |
4
| Doyle Anthony (CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Bought 35,258 shares
@ $12.48, valued at
$440k
|
|
| 12/17/2020 |
4
| Doyle Anthony (CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 332,500 options to buy
@ $8.31, valued at
$2.8M
|
|
| 08/12/2020 |
4
| Doyle Anthony (CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Bought 54,000 shares
@ $4.08, valued at
$220.3k
|
|
| 05/04/2020 |
4
| Doyle Anthony (CFO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 600,000 options to buy
@ $3.91, valued at
$2.3M
|
|
| 04/08/2020 |
3
| Doyle Anthony (CFO) has filed a Form 3 on BIOCRYST PHARMACEUTICALS INC |
|
|